"Glucosamine/pharmacokinetics"[MAJR] - Search Results

Year	Number of Results
1988	1
1990	1
1991	1
1993	1
2000	1
2001	2
2002	2
2003	1
2004	2
2005	3
2007	1
2008	3
2009	7
2010	4
2011	4
2012	5
2013	5
2014	4
2016	1
2018	2
2019	1
2021	1
2024	0

1

Variation in the pharmacokinetics of glucosamine in healthy individuals.

Asthana C, Peterson GM, Shastri MD, Patel RP. Asthana C, et al. Rheumatology (Oxford). 2021 Mar 2;60(3):1205-1209. doi: 10.1093/rheumatology/keaa418. Rheumatology (Oxford). 2021. PMID: 32901283 Clinical Trial.

2

Pharmacokinetics of glucosamine in man.

Setnikar I, Palumbo R, Canali S, Zanolo G. Setnikar I, et al. Arzneimittelforschung. 1993 Oct;43(10):1109-13. Arzneimittelforschung. 1993. PMID: 8267678

3

Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man.

Persiani S, Roda E, Rovati LC, Locatelli M, Giacovelli G, Roda A. Persiani S, et al. Osteoarthritis Cartilage. 2005 Dec;13(12):1041-9. doi: 10.1016/j.joca.2005.07.009. Epub 2005 Sep 13. Osteoarthritis Cartilage. 2005. PMID: 16168682 Free article. Clinical Trial.

4

Comparison of pharmacokinetics of glucosamine and synovial fluid levels following administration of glucosamine sulphate or glucosamine hydrochloride.

Meulyzer M, Vachon P, Beaudry F, Vinardell T, Richard H, Beauchamp G, Laverty S. Meulyzer M, et al. Osteoarthritis Cartilage. 2008 Sep;16(9):973-9. doi: 10.1016/j.joca.2008.01.006. Epub 2008 Mar 4. Osteoarthritis Cartilage. 2008. PMID: 18295513 Free article.

5

Glucosamine: a review of its use in the management of osteoarthritis.

Matheson AJ, Perry CM. Matheson AJ, et al. Drugs Aging. 2003;20(14):1041-60. doi: 10.2165/00002512-200320140-00004. Drugs Aging. 2003. PMID: 14651444 Review.

6

Single dose pharmacokinetics and bioavailability of glucosamine in the rat.

Aghazadeh-Habashi A, Sattari S, Pasutto F, Jamali F. Aghazadeh-Habashi A, et al. J Pharm Pharm Sci. 2002 May-Aug;5(2):181-4. J Pharm Pharm Sci. 2002. PMID: 12207871 Free article.

7

Absorption and bioavailability of glucosamine in the rat.

Ibrahim A, Gilzad-kohan MH, Aghazadeh-Habashi A, Jamali F. Ibrahim A, et al. J Pharm Sci. 2012 Jul;101(7):2574-83. doi: 10.1002/jps.23145. Epub 2012 Apr 4. J Pharm Sci. 2012. PMID: 22488120

8

The glucosamine controversy; a pharmacokinetic issue.

Aghazadeh-Habashi A, Jamali F. Aghazadeh-Habashi A, et al. J Pharm Pharm Sci. 2011;14(2):264-73. doi: 10.18433/j3xg6f. J Pharm Pharm Sci. 2011. PMID: 21733414 Free article. Review.

9

The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs.

Adebowale A, Du J, Liang Z, Leslie JL, Eddington ND. Adebowale A, et al. Biopharm Drug Dispos. 2002 Sep;23(6):217-25. doi: 10.1002/bdd.315. Biopharm Drug Dispos. 2002. PMID: 12214321

10

The human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combination.

Jackson CG, Plaas AH, Sandy JD, Hua C, Kim-Rolands S, Barnhill JG, Harris CL, Clegg DO. Jackson CG, et al. Osteoarthritis Cartilage. 2010 Mar;18(3):297-302. doi: 10.1016/j.joca.2009.10.013. Epub 2009 Nov 10. Osteoarthritis Cartilage. 2010. PMID: 19912983 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

46 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year